1. Home
  2. CRK vs OGN Comparison

CRK vs OGN Comparison

Compare CRK & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comstock Resources Inc.

CRK

Comstock Resources Inc.

HOLD

Current Price

$14.94

Market Cap

4.0B

Sector

Energy

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

SELL

Current Price

$13.77

Market Cap

3.6B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CRK
OGN
Founded
1983
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.6B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
CRK
OGN
Price
$14.94
$13.77
Analyst Decision
Hold
Hold
Analyst Count
16
4
Target Price
★ $15.30
$10.33
AVG Volume (30 Days)
★ 2.4M
2.0M
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
★ 0.58%
EPS Growth
★ 288.16
N/A
EPS
0.40
★ 0.95
Revenue
$555,231,000.00
★ $6,216,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.07
P/E Ratio
$37.15
★ $14.46
Revenue Growth
★ 32.11
N/A
52 Week Low
$12.12
$5.69
52 Week High
$28.10
$13.83

Technical Indicators

Market Signals
Indicator
CRK
OGN
Relative Strength Index (RSI) 63.77 56.17
Support Level $12.49 $13.72
Resistance Level $15.22 $13.78
Average True Range (ATR) 0.55 0.04
MACD 0.14 -0.00
Stochastic Oscillator 96.91 43.48

Price Performance

Historical Comparison
CRK
OGN

About CRK Comstock Resources Inc.

Comstock Resources Inc is an independent natural gas producer operating in the Haynesville shale, a natural gas basin located in North Louisiana and East Texas with superior economics given its geographical proximity to the Gulf Coast natural gas markets. The Company operates in one business segment, the exploration and production of North American natural gas and oil. It is engaged in the acquisition, development, production, and exploration of oil and natural gas. The company's oil and gas operations are concentrated in Louisiana and Texas.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: